Changes in the anti-oxidant system in adult epilepsy patients receiving anti-epileptic drugs

References

• Akıncıoğlu A, Topal M, Gülçin I, Göksu S. (2014). Novel sulfamides and sulfonamides incorporating tetralin scaffold as carbonic anhydrase and acetylcholine esterase inhibitors. Arch Pharm, 347:68–76
   PubMed Web of Science ®Google Scholar
• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72:248–54
   PubMed Web of Science ®Google Scholar
• Chaudhary S, Parvez S. (2012). An in vitro approach to assess the neurotoxicity of valproic acid-induced oxidative stress in cerebellum and cerebral cortex of young rats. Neuroscience, 225:258–68
   PubMed Web of Science ®Google Scholar
• Cuı J, Shao L, Young LT, Wang JF. (2007). Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience, 144:1447–53
   PubMed Web of Science ®Google Scholar
• De Luca A, Hartinger CG, Dyson PJ, et al. (2013). A new target for gold(I) compounds: Glutathione-S-transferase inhibition by auranofin. J Inorg Biochem, 119:38–42
   PubMed Web of Science ®Google Scholar
• Dilek EB, Kufrevioglu Öİ, Beydemir Ş. (2013) Impacts of some antibiotics on human serum paraoxonase 1 activity. J Enzym Inhib, 28(4):758–64
   Google Scholar
• Ellman GL, Courtney DK, Andres V, Featherstone RM. (1961). A new and rapid colorimetric determination of acetyl cholinesterase activity. Biochem Pharmacol, 7:88–95
   PubMed Web of Science ®Google Scholar
• Ficarra S, Misiti F, Russo A, et al. (2013). Anti-epileptic carbamazepine drug treatment induces alteration of membrane in red blood cells: Possible positive effects on metabolism and oxidative stress. Biochimie, 95:833–41
   PubMed Web of Science ®Google Scholar
• Frantseva MV, Perez Valazquez JL, Tsorakkidis G, et al. (2000). Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy. Neuroscience, 97(3):431–5
   PubMed Web of Science ®Google Scholar
• Garcia-Morales I, Sancho Rieger J, Gil-Nagel A, Herranz Fernandez JL. (2007). Anti-epileptic drugs: From scientific evidence to clinical practice. Neurologist, 13:S20–8
   PubMed Web of Science ®Google Scholar
• Gocer H, Akincioglu A, Oztaskin, N, et al. (2013). Synthesis, anti-oxidant, and antiacetyl cholinesterase activities of sulfonamide derivatives of dopamine-related compounds. Arch Pharm, 346:783–92
   PubMed Web of Science ®Google Scholar
• Gülçin İ. (2012). Anti-oxidant activity of food constituents: An overview. Arch Toxicol, 86:345–91
   PubMed Web of Science ®Google Scholar
• Gülçin İ, Beydemir S. (2013). Phenolic compounds as anti-oxidants: Carbonic anhydrase isoenzymes inhibitors. Mini-Rev Med Chem, 13:408–30
   PubMed Web of Science ®Google Scholar
• Habig WH, Pabst MJ, Jakoby WB. (1974). Glutathione S-transferases, the first enzymatic step in mercapturic acid formation. J Biol Chem, 249:7130–9
   PubMed Web of Science ®Google Scholar
• Harvey JW, Beutler E. (1982). Binding of heme by glutathiones S-transferases: A possible role of erythrocyte enzyme. Blood, 60:1227–30
   PubMed Web of Science ®Google Scholar
• Hauser WA. (1994). The prevalence and incidence of convulsive disorders in children. Epilepsia, 35(Suppl. 2):S1–6
   PubMed Web of Science ®Google Scholar
• Johannessen CU, Johannessen SI (2003). Valproate: Past, present and future. CNS Drug Rev, 9:199–216
   PubMedGoogle Scholar
• Johannessen Landmark C, Larsson PG, Rytter E, Johannessen, SI. (2009). Anti-epileptic drugs in epilepsy and other disorders: A-population based study of prescriptions. Epilepsy Res, 87:31–9
   PubMed Web of Science ®Google Scholar
• Johannessen Landmark, C. (2008). Relations between mechanisms of action and clinical efficacy of anti-epileptic drug in non-epilepsy condition. CNS Drugs, 22:27–47
   PubMed Web of Science ®Google Scholar
• Karikas GA, Schulpis KH, Bartzeliotou A, et al. (2009). Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities. Scand J Clin Lab Invest, 69(1):31–5
   PubMed Web of Science ®Google Scholar
• Khan MM, Ahmad A, Ishrat T, et al. (2010). Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson’s disease. Brain Res, 1328:139–51
   PubMed Web of Science ®Google Scholar
• Kiang TK, Teng XW, Surendradoss J, et al. (2011). Glutathione depletion by valproic acid in sandwich-cultured rat hepatocytes: Role of biotransformation and temporal relationship with onset of toxicity. Toxicol Appl Pharmacol, 252:318–24
   PubMed Web of Science ®Google Scholar
• Kurekci AE, Alpay F, Tanindi S, et al. (1995). Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving anti-epileptic drug therapy. Epilepsia, 36:600–4
   PubMed Web of Science ®Google Scholar
• Lindhout DH, Oppener RJ, Meinardi H. (1984). Teratogenicity of anti-epileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia, 25:77–83
   PubMed Web of Science ®Google Scholar
• Lu SC. (1999). Regulation of hepatic glutathione synthesis: Current concepts and controversies. The FASEB J, 13(10):1169–83
   PubMed Web of Science ®Google Scholar
• Mizuno K, Okada M, Murakami T, et al. (2000). Effects of carbamazepine on acetylcholine release and metabolism. Epilepsy Res, 40:187–95
   PubMed Web of Science ®Google Scholar
• Ono H, Sakamoto A, Sakura N. (2000). Plasma total glutathione concentrations in epileptic patients taking anticonvulsants. Clin Chim Acta, 298(1–2):135–43
   PubMed Web of Science ®Google Scholar
• Patel MN. (2002). Oxidative stres, mitochondrial dysfunction, and epilepsy. Free Rad Res, 36:1139–46
   PubMed Web of Science ®Google Scholar
• Phyu MP, Tangpong J. (2014). Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetyl cholinesterase dysfunction and cognitive impairment. Food Chem Toxicol, 70:151–6
   PubMed Web of Science ®Google Scholar
• Reddy YN, Murthy SV, Krishna DR, Prabhakar MC. (2004). Role of free radicals and anti-oxidants in tuberculosis patients. Indian J Tuberc, 51:213–18
   Google Scholar
• Reiter RJ, Tan DX, Sainz RM, et al. (2002). Melatonin:reducing the toxicity and increasing the efficacy of drug. J Pharm Pharmacol, 54:1299–321
   PubMed Web of Science ®Google Scholar
• Renault F, Chabriere E, Andrieu JP, et al. (2006). Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography. J Chromatogr B, 836:15–21
   PubMed Web of Science ®Google Scholar
• Roy R, Chaudhuri AN. (2006). Differential acetyl cholinesterase activity in rat cerebrum, cerebellum and hypothalamus. Indian J Exp Biol, 44:381–6
   PubMedGoogle Scholar
• Rozenberg O, Aviram M. (2006). S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. Biochem Biophy Res Commun, 351:492–8
   PubMed Web of Science ®Google Scholar
• Siebel AM, Rico EP, Capiotti KM, et al. (2010). In vitro effects of anti-epileptic drugs on acetyl cholinesterase and ectonucleotidase activities in zebrafish (Danio rerio) brain. Toxicol in Vitro, 24:1279–84
   PubMed Web of Science ®Google Scholar
• Tong V, Teng XW, Chang Thomas KH, Abbott FS. (2005a). Valproic acid I: Time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats. Toxicol Sci, 86(2):427e35
   Google Scholar
• Tong V, Teng XW, Karagiozov S, et al. (2005b). Valproic acid glucuronidation is associated with increase in 15- F2t-isoprostane in rats. Free Radic Bio Med, 38:1471e83
   Web of Science ®Google Scholar
• Turkeş C, Soyut H, Beydemir Ş. (2014). Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress. Pharmacol Rep, 66(1):74–80
   PubMed Web of Science ®Google Scholar
• Verrotti A, Scardapane A, Franzoni E, et al. (2008). Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res, 78(2–3):171–7
   PubMed Web of Science ®Google Scholar
• Veskoukis AS, Nikolaidis MG, Kyparos A, et al. (2008). Effects of xanthine oxidase inhibition on oxidative stress and swimming performance in rats. Appl Physiol Nutr Metab, 33(6):1140–54
   PubMed Web of Science ®Google Scholar
• Wallace SJ. (1996). A comparative review of the adverse effects of anticonvulsant in children with epilepsy. Drug Safe, 15:378–93
   PubMed Web of Science ®Google Scholar
• Yüksel A, Cengiz M, Seven M, Ulutin T. (2001). Changes in the anti-oxidant system in epileptic children receiving anti-epileptic drugs: Two-year prospective studies. J Child Neurol, 16(8):603–606
   PubMed Web of Science ®Google Scholar
• Zhanga XZ, Li XJ, Zhangb HY. (2010). Valproic acid as a promising agent to combat Alzheimer’s disease. Brain Res Bull, 81:3–6
   PubMed Web of Science ®Google Scholar